The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Dysfunctional HDL and atherosclerotic cardiovascular disease
Open accessAbstract
High-density lipoproteins (HDLs) protect against atherosclerosis by removing excess cholesterol from macrophages through the ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1) pathways involved in reverse cholesterol transport. Factors that impair the availability of functional apolipoproteins or the activities of ABCA1 and ABCG1 could, therefore, strongly influence atherogenesis. HDL also inhibits lipid oxidation, restores endothelial function, exerts anti-inflammatory and antiapoptotic actions, and exerts anti-inflammatory actions in animal models. Such properties could contribute considerably to the capacity of HDL to inhibit atherosclerosis. Systemic and vascular inflammation has been proposed to convert HDL to a dysfunctional form that has impaired antiatherogenic effects. A loss of anti-inflammatory and antioxidative proteins, perhaps in combination with a gain of proinflammatory proteins, might be another important component in rendering HDL dysfunctional. The proinflammatory enzyme myeloperoxidase induces both oxidative modification and nitrosylation of specific residues on plasma and arterial apolipoprotein A-I to render HDL dysfunctional, which results in impaired ABCA1 macrophage transport, the activation of inflammatory pathways, and an increased risk of coronary artery disease. Understanding the features of dysfunctional HDL or apolipoprotein A-I in clinical practice might lead to new diagnostic and therapeutic approaches to atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies have indicated a complete loss of function and dysfunction gain concerning anti-inflammatory, vasodilatory, and antiapoptotic activities.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“However, there are instances where HDL’s ability to deliver cholesterol esters via SCARB1 may be reduced, indicating only a partial loss of function.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“It was noted that HDL could lose its anti-inflammatory properties and even develop proinflammatory characteristics.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“However, when it comes to antioxidative activity and cholesterol efflux capacity, the deficiency observed in HDL’s normal function falls short of complete dysfunction [9].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Subsequent research has shown that the extent of HDL’s normal function loss and dysfunction gain can vary depending on its different biological activities.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Dysfunctional HDL (dys-HDL) are HDL cholesterol particles with high pro-atherogenic characteristics, characterized by the loss of typical antioxidant properties, becoming carriers of oxidized lipids themselves.”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [9]
In the citing paper
“Moreover, modulations in HDL particle composition can transform it to dysfunctional and, through this modulation, increase the risk of CVD40.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [40]
In the citing paper
“Decrease in HDL has been regarded as one important risk factor for cardiovascular diseases40.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationEffects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Self-citationWiller (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Self-citationCholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
HDL cholesterol efflux capacity and incident cardiovascular events
Rohatgi, A., Khera, A., Berry, J. D., Givens, E. G., Ayers, C. R., Wedin, K. E., Neeland, I. J., Yuhanna, I. S., Rader, D. R., de Lemos, J. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409065 · Cited by 1,390
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Self-citationCholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953
Self-citationCommon variants associated with plasma triglycerides and risk for coronary artery disease
Do, R., Willer, C. J., Schmidt, E. M., Sengupta, S., Gao, C., Peloso, G. M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2795 · Cited by 862
Lenten, B. J. V., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., Du, B. N. L., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 839
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 754
Yuhanna, I. S., Zhu, Y., Cox, B. E., Hahner, L., Osborne-Lawrence, S. L., Lu, P., Marcel, Y. L., Anderson, R. G. W., Mendelsohn, M. E., Hobbs, H. H., et al. (2001) · Nature Medicine · doi:10.1038/89986 · Cited by 753
Safety of anacetrapib in patients with or at high risk for coronary heart disease
Cannon, C. P., Shah, S., Dansky, H. M., Davidson, M., Brinton, E. A., Gotto, A. M., Stepanavage, M., Liu, S. X., Gibbons, P., Ashraf, T. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009744 · Cited by 749
Self-citationMendelian randomization of blood lipids for coronary heart disease
Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/eht571 · Cited by 748
Zheng, L., Nukuna, B. N., Brennan, M., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21109 · Cited by 735
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 663
Ansell, B. J., Navab, M., Hama, S. Y., Kamranpour, N., Fonarow, G. C., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 588
Self-citationNanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
Nahrendorf, M., Zhang, H., Hembrador, S., Panizzi, P., Sosnovik, D. E., Aikawa, E., Libby, P., Swirski, F. K., & Weissleder, R. (2008) · Circulation · doi:10.1161/circulationaha.107.741181 · Cited by 559
Besler, C., Heinrich, K., Rohrer, L., Doerries, C., Riwanto, M., Shih, D. M., Chroni, A., Yonekawa, K., Stein, S., Schaefer, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42946 · Cited by 535
Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 523
Self-citationSaleheen, D., Scott, R. A., Javad, S., Zhao, W., Rodrigues, A., Picataggi, A., Lukmanova, D., Mucksavage, M. L., Luben, R., Billheimer, J. T., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00126-6 · Cited by 479
Hansel, B., Giral, P., Nobécourt, E., Chantepie, S., Bruckert, É., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 476
Self-citationBergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Self-citationHigh-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men
Spieker, L. E., Sudano, I., Hürlimann, D., Lerch, P. G., Lang, M. G., Binggeli, C., Corti, R., Ruschitzka, F. T., Lüscher, T. F., & Noll, G. (2002) · Circulation · doi:10.1161/01.cir.0000013424.28206.8f · Cited by 437
Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H., Jeenah, M. S., & de Beer, F. C. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67562-3 · Cited by 426
Nicholls, S. J., Brewer, H. B., Kastelein, J. J. P., Krueger, K. A., Wang, M.-D., Shao, M., Hu, B., McErlean, E., & Nissen, S. E. (2011) · JAMA · doi:10.1001/jama.2011.1649 · Cited by 410
Self-citationHigh-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 404
Sorrentino, S. A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F. H., Mueller, M., Horváth, T., Doerries, C., Heinemann, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.836346 · Cited by 402
Inflammation Impairs Reverse Cholesterol Transport In Vivo
McGillicuddy, F. C., Moya, M. D. L. L., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 392
An abundant dysfunctional apolipoprotein A1 in human atheroma
Huang, Y. R., DiDonato, J. A., Levison, B. S., Schmitt, D., Li, L., Wu, Y., Buffa, J. A., Kim, T., Gerstenecker, G. S., Gu, X., et al. (2014) · Nature Medicine · doi:10.1038/nm.3459 · Cited by 369
Riwanto, M., Rohrer, L., Roschitzki, B., Besler, C., Mocharla, P., Mueller, M., Perisa, D., Heinrich, K., Altwegg, L., von Eckardstein, A., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.108753 · Cited by 337
Baldus, S. E., Eiserich, J. P., Mani, A. R., Castro, L., Figueroa, M., Chumley, P. H., Ma, W., Tousson, A., White, C. R., Bullard, D. C., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12617 · Cited by 332
Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids
Camont, L., Lhomme, M., Rached, F. H., Goff, W. L., Nègre‐Salvayre, A., Salvayre, R., Calzada, C., Lagarde, M., Chapman, M. J., & Kontush, A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301468 · Cited by 330
Self-citationHigh-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection
Lenten, B. J. V., Wagner, A. C., Nayak, D. P., Hama, S. Y., Navab, M., & Fogelman, A. M. (2001) · Circulation · doi:10.1161/01.cir.103.18.2283 · Cited by 323
Speer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310
HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export
Du, X.-M., Kim, M., Hou, L., Goff, W. L., Chapman, M. J., Eck, M. V., Curtiss, L. K., Burnett, J. R., Cartland, S. P., Quinn, C. M., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.305485 · Cited by 309
Self-citationParadoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks
Li, X.-M., Tang, W. H. W., Mosior, M. K., Huang, Y., Wu, Y., Matter, W., Gao, V., Schmitt, D., DiDonato, J. A., Fisher, E. A., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301373 · Cited by 301
Lüscher, T. F., Landmesser, U., von Eckardstein, A., & Fogelman, A. M. (2014) · Circulation Research · doi:10.1161/circresaha.114.300935 · Cited by 299
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Kontush, A., & Chapman, M. J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833bcdc1 · Cited by 294
Self-citationBisoendial, R. J., Hovingh, G. K., Levels, J. H. M., Lerch, P. G., Andresen, I., Hayden, M. R., Kastelein, J. J. P., & Stroes, E. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000070934.69310.1a · Cited by 287
Baldus, S. E., Eiserich, J. P., Mani, A. R., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112617 · Cited by 281
Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
Undurti, A., Huang, Y. R., Lupica, J. A., Smith, J. D., DiDonato, J. A., & Hazen, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047605 · Cited by 267
Pennathur, S., Bergt, C., Shao, B., Byun, J., Kassim, S. Y., Singh, P., Green, P. S., McDonald, T. O., Brunzell, J. D., Chait, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406762200 · Cited by 263
Self-citationATP-Binding Cassette Transporters, Atherosclerosis, and Inflammation
Westerterp, M., Bochem, A. E., Yvan‐Charvet, L., Murphy, A. J., Wang, N., & Tall, A. R. (2014) · Circulation Research · doi:10.1161/circresaha.114.300738 · Cited by 261
Self-citationGenetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease
Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S., & Gaudet, D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.042 · Cited by 260
Self-citationYvan‐Charvet, L., Kling, J., Pagler, T. A., Li, H., Hubbard, B. K., Fisher, T., Sparrow, C. P., Taggart, A. K. P., & Tall, A. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207142 · Cited by 242
Self-citationShao, B., Bergt, C., Fu, X., Green, P., Voss, J. C., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411484200 · Cited by 227
Self-citationTranslation of High-Density Lipoprotein Function Into Clinical Practice
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P. J., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2013) · Circulation · doi:10.1161/circulationaha.113.000962 · Cited by 225
Self-citationFöger, B., Chase, M. B., Amar, M. J., Vaisman, B. L., Shamburek, R. D., Paigen, B. J., Fruchart‐Najib, J., Paiz, J. A., Koch, C. A., Hoyt, R. F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.36912 · Cited by 224
Self-citationNob�court, E., Jacqueminet, S., Hansel, B., Chantepie, S., Grimaldi, A., Chapman, M. J., & Kontush, A. (2005) · Diabetologia · doi:10.1007/s00125-004-1655-5 · Cited by 222
Self-citationInflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
Vaisar, T., Tang, C., Babenko, I., Hutchins, P. M., Wimberger, J., Suffredini, A. F., & Heinecke, J. W. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059089 · Cited by 217
Self-citationNicholls, S. J., Lundman, P., Harmer, J. A., Cutri, B., Griffiths, K. A., Rye, K.-A., Barter, P. J., & Celermajer, D. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.080 · Cited by 216
Self-citationBérard, A. M., Föger, B., Remaley, A. T., Shamburek, R. D., Vaisman, B. L., Talley, G. D., Paigen, B. J., Hoyt, R. F., Marcovina, S. M., Brewer, H. B., et al. (1997) · Nature Medicine · doi:10.1038/nm0797-744 · Cited by 209
Self-citationKawakami, A., Aikawa, M., Libby, P., Alcaide, P., Luscinskas, F. W., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.105.591743 · Cited by 206
Shao, B., Tang, C., Sinha, A., Mayer, P. S., Davenport, G. D., Brot, N., Oda, M. N., Zhao, X.-Q., & Heinecke, J. W. (2014) · Circulation Research · doi:10.1161/circresaha.114.303454 · Cited by 201
Self-citationAnti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
Morgantini, C., Natali, A., Boldrini, B., Imaizumi, S., Navab, M., Fogelman, A. M., Ferrannini, E., & Reddy, S. T. (2011) · Diabetes · doi:10.2337/db11-0378 · Cited by 200
Nahrendorf, M., Sosnovik, D. E., Chen, J. W., Panizzi, P. R., Figueiredo, J., Aïkawa, E., Libby, P., Świrski, F. K., & Weissleder, R. (2008) · Circulation · doi:10.1161/circulationaha.107.756510 · Cited by 199
The HDL proteome in acute coronary syndromes shifts to an inflammatory profile
Al-Waili, K., Bailey, D., Awan, Z. A., Bailey, S. D., Ruel, I. L., Hafiane, A., Krimbou, L., LaBoissière, S., & Genest, J. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.013 · Cited by 198
Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
Banka, C. L., Yuan, T., de Beer, M. C., Kindy, M. S., Curtiss, L. K., & de Beer, F. C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39863-1 · Cited by 197
Tietge, U., Maugeais, C., Cain, W. J., Grass, D., Glick, J., de Beer, F. D., & Rader, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10077 · Cited by 190
Myeloperoxidase: An Oxidative Pathway for Generating Dysfunctional High-Density Lipoprotein
Shao, B., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx9003775 · Cited by 189
Self-citationMethionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I
Shao, B., Cavigiolio, G., Brot, N., Oda, M. N., & Heinecke, J. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802025105 · Cited by 189
Self-citationPharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib
Tardif, J., Rhéaume, É., Perreault, L. L., Grégoire, J. C., Zada, Y. F., Asselin, G., Provost, S., Barhdadi, A., Rhainds, D., L’Allier, P. L., et al. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000663 · Cited by 183
Roberts, C. K., Ng, C. J., Hama, S. Y., Eliseo, A. J. Y., & Barnard, R. J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00345.2006 · Cited by 178
Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211126200 · Cited by 175
Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice
McMillen, T. S., Heinecke, J. W., & LeBoeuf, R. C. (2005) · Circulation · doi:10.1161/circulationaha.104.516278 · Cited by 168
Self-citationRonald, J. A., Chen, J. W., Chen, Y., Hamilton, A. M., Rodríguez, E., Reynolds, F., Hegele, R. A., Rogers, K. A., Querol, M., Bogdanov, A. A., Jr., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.813998 · Cited by 164
Zerrad-Saadi, A., Thérond, P., Chantepie, S., Couturier, M., Rye, K., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194555 · Cited by 159
Self-citationPlasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Voight, B. F., Peloso, G. M., Orho-Melander, M., Frikke-Schmidt, R., Barbalic, M., Jensen, M. K., Hindy, G., Hólm, H., Ding, E. L., Johnson, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60312-2 · Cited by 148
Hewing, B., Parathath, S., Barrett, T. J., Chung, W. K. K., Astudillo, Y., Hamada, T., Ramkhelawon, B., Tallant, T. C., Yusufishaq, M., DiDonato, J., et al. (2014) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303044 · Cited by 147
Jensen, M. K., Rimm, E. B., Furtado, J. D., & Sacks, F. M. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000232 · Cited by 142
Kontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.001 · Cited by 141
Self-citationHan, C. Y., Chiba, T., Campbell, J. S., Fausto, N., Chaisson, M. L., Orasanu, G., Plutzky, J., & Chait, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000227472.70734.ad · Cited by 140
Cabana, V. G., Lukens, J. R., Rice, K. S., Hawkins, T., & Getz, G. S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37469-1 · Cited by 129
Souza, J. A., Vindis, C., Hansel, B., Nègre‐Salvayre, A., Thérond, P., Junior, C. V. S., Chantepie, S., Salvayre, R., Bruckert, É., Chapman, M. J., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.009 · Cited by 125
Self-citationVaisman, B. L., Klein, H., Rouis, M., Bérard, A. M., Kindt, M. R., Talley, G. D., Meyn, S. M., Hoyt, R. F., Marcovina, S. M., Albers, J. J., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12269 · Cited by 125
Self-citationEffects of cigarette smoking on HDL quantity and function: Implications for atherosclerosis
He, B., Zhao, S., & Peng, Z. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24581 · Cited by 123
Bergt, C., Fu, X., Saifee, N. H., Kao, J. L.-F., & Heinecke, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309046200 · Cited by 123
Self-citationWhy is HDL functionally deficient in type 2 diabetes?
Kontush, A., & Chapman, M. J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0010-5 · Cited by 116
Self-citationPerségol, L., Vergès, B. L., Foissac, M., Gambert, P., & Duvillard, L. (2006) · Diabetologia · doi:10.1007/s00125-006-0244-1 · Cited by 104
Guérin, M., Egger, P., Soudant, C., Goff, W. L., van Tol, A., Dupuis, R., & Chapman, M. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00037-0 · Cited by 99
Self-citationPeng, D.-Q., Brubaker, G., Wu, Z., Zheng, L., Willard, B. B., Kinter, M. T., Hazen, S. L., & Smith, J. D. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173815 · Cited by 99
DiDonato, J. A., Aulak, K. S., Huang, Y. R., Wagner, M. A., Gerstenecker, G. S., Topbas, C., Gogonea, V., DiDonato, A. J., Tang, W. H. W., Mehl, R. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556506 · Cited by 96
Shao, B., Tang, C., Heinecke, J. W., & Oram, J. F. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004085 · Cited by 96
Self-citationMyeloperoxidase Generates 5-Chlorouracil in Human Atherosclerotic Tissue
Takeshita, J., Byun, J., Nhan, T. Q., Pritchard, D. K., Pennathur, S., Schwartz, S. M., Chait, A., & Heinecke, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509236200 · Cited by 95
Self-citationBagdade, J. D., Buchanan, W., Kuusi, T., & Taskinen, M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.232 · Cited by 95
Patel, S., Puranik, R., Nakhla, S., Lundman, P., Stocker, R., Wang, X., Lambert, G. C., Rye, K.-A., Barter, P. J., Nicholls, S. J., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.047 · Cited by 92
Self-citationRay, K. K., Ditmarsch, M., Kallend, D. G., Niesor, E. J., Suchánková, G., Upmanyu, R., Anzures‐Cabrera, J., Lehnert, V., Pauly-Evers, M., Holme, I., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu105 · Cited by 88
Aron‐Wisnewsky, J., Julia, Z., Poitou, C., Bouillot, J., Basdevant, A., Chapman, M. J., Clément, K., & Guérin, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2378 · Cited by 87
Self-citationHoofnagle, A. N., Wu, M., Gosmanova, A. K., Becker, J. O., Wijsman, E. M., Brunzell, J. D., Kahn, S. E., Knopp, R. H., Lyons, T. J., & Heinecke, J. W. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.212894 · Cited by 87
Self-citationBrites, F. D., Bonavita, C. D., Geitere, C. D., Cloës, M., Delfly, B., Yael, M. J., Fruchart, J., Wikinski, R. L. W., & Castro, G. R. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00452-9 · Cited by 83
Kontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118276.87061.00 · Cited by 79
Self-citationCastro‐Perez, J. M., Briand, F., Gagen, K., Wang, S., Chen, Y., McLaren, D. G., Shah, V., Vreeken, R. J., Hankemeier, T., Sulpice, T., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m016410 · Cited by 78
Heinecke, J. W. (1997) · BioFactors · doi:10.1002/biof.5520060208 · Cited by 78
Self-citationKhera, A. V., Patel, P. J., Reilly, M. P., & Rader, D. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.025 · Cited by 74
de Beer, F. C., Connell, P. M., Yu, J., de Beer, M. C., Webb, N. R., & van der Westhuyzen, D. R. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31979-9 · Cited by 72
Self-citationAbnormal Reverse Cholesterol Transport in Controlled Type II Diabetic Patients
Cavallero, E., Brites, F. D., Delfly, B., Nicolaı̈ew, N., Decossin, C., Geitere, C. D., Fruchart, J., Wikinski, R. L. W., JACOTOT, B., & Castro, G. R. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2130 · Cited by 71
Niesor, E. J., Schwartz, G. G., Perez, A., Stauffer, A., Durrwell, A., Suchánková, G., Benghozi, R., Abt, M., & Kallend, D. G. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6570-0 · Cited by 70
Kriska, T., Marathe, G. K., Schmidt, J. C., McIntyre, T. M., & Girotti, A. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608135200 · Cited by 70
Secretory phospholipase A2: A multifaceted family of proatherogenic enzymes
Rosenson, R. S., & Gelb, M. H. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0064-2 · Cited by 70
Self-citationCatalano, G., Julia, Z., Frisdal, É., Vedie, B., Fournier, N., Goff, W. L., Chapman, M. J., & Guérin, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179416 · Cited by 69
Self-citationMiyamoto–Sasaki, M., Yasuda, T., Monguchi, T., Nakajima, H., Mori, K., Toh, R., Ishida, T., & Hirata, K. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17210 · Cited by 67
Perségol, L., Foissac, M., Lagrost, L., Athias, A., Gambert, P., Vergès, B. L., & Duvillard, L. (2007) · Diabetologia · doi:10.1007/s00125-007-0808-8 · Cited by 67
Patel, P. J., Khera, A. V., Wilensky, R. L., & Rader, D. J. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft084 · Cited by 63
Birjmohun, R. S., Vergeer, M., Stroes, E. S. G., Sandhu, M. S., Ricketts, S. L., Tanck, M. W. T., Wareham, N. J., Jukema, J. W., Kastelein, J. J. P., Khaw, K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006809 · Cited by 62
Airan‐Javia, S., Wolf, R. L., Wolfe, M. L., Tadesse, M. G., Mohler, E. R., & Reilly, M. P. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.01.001 · Cited by 62
Rached, F. H., Lhomme, M., Camont, L., Gomes, F. L. T., Dauteuille, C., Robillard, P., Santos, R. D., Lesnik, P., Junior, C. V. S., Chapman, M. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.05.007 · Cited by 61
Self-citationMarsillach, J., Becker, J. O., Vaisar, T., Hahn, B. H., Brunzell, J. D., Furlong, C. E., de Boer, I. H., McMahon, M. A., Hoofnagle, A. N., & DCCT/EDIC Research Group (2015) · Journal of Proteome Research · doi:10.1021/pr5011586 · Cited by 60
Ballantyne, C. M., Miller, M. J., Niesor, E. J., Burgess, T., Kallend, D. G., & Stein, E. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.11.017 · Cited by 59
Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism
de Beer, F. C., de Beer, M. C., van der Westhuyzen, D. R., Castellani, L. W., Lusis, A. J., Swanson, M. E., & Grass, D. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34937-3 · Cited by 56
Zhang, C., Peng, W., WANG, M., Zhu, J., Zang, Y., Shi, W., Zhang, J., & Qin, J. (2010) · Gene Therapy · doi:10.1038/gt.2010.11 · Cited by 49
Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome
Rosenson, R. S., Brewer, H. B., & Rader, D. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302805 · Cited by 45
Self-citationPark, K.-H., Shin, D., & Cho, K. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu076 · Cited by 44
A High Throughput Biochemical Fluorometric Method for Measuring Lipid Peroxidation in HDL
Kelesidis, T., Roberts, C. K., Huynh, D., Martínez-Maza, O., Currier, J. S., Reddy, S. T., & Yang, O. O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111716 · Cited by 41
Zhao, Y., Sparks, D. L., & Marcel, Y. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25145 · Cited by 38
Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma
Miyazaki, O., Ogihara, J., Fukamachi, I., & Kasumi, T. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m041038 · Cited by 37
Song, W., Wang, W., Dou, L.-Y., Wang, Y., Xu, Y., Chen, L., & Yan, X. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p055491 · Cited by 36
Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice
Dugi, K. A., Vaisman, B. L., Sakai, N., Knapper, C. L., Meyn, S. M., Brewer, H. B., & Santamarina-Fojo, S. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37156-x · Cited by 33
Self-citationMendelian randomisation, lipids, and cardiovascular disease
Harrison, S. C., Holmes, M. V., & Humphries, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60481-4 · Cited by 31
de Carvalho, L. S. F., Panzoldo, N. B., dos Santos, S. N., Modolo, R., Almeida, B. O., Silva, J. C. Q. E., Nadruz, W., de Faria, E. C., & Sposito, A. C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.103 · Cited by 31
Pirillo, A., Uboldi, P., Bolego, C., Kühn, H., & Catapano, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2821 · Cited by 30
Wroblewski, J. M., Jahangiri, A., Ji, A., de Beer, F. C., van der Westhuyzen, D. R., & Webb, N. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017681 · Cited by 28
Self-citationDisorders in High-Density Metabolism With Insulin Resistance and Chronic Kidney Disease
Kaysen, G. A. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.10.002 · Cited by 27
C-Reactive Protein, Serum Amyloid A Protein, and Coronary Events
Choudhury, R. P., & Leyva, F. (1999) · Circulation · doi:10.1161/01.cir.100.15.e65 · Cited by 26
Reduction of cold ischemia–reperfusion injury by graft-expressing clusterin in heart transplantation
Li, S., Guan, Q., Chen, Z., Gleave, M. E., Nguan, C. Y. C., & Du, C. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.03.007 · Cited by 25
Kelesidis, T., Reddy, S. T., Huynh, D., Meriwether, D., Fogelman, A. M., Navab, M., & Yang, O. O. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-87 · Cited by 24
Kar, S., Patel, M. A., Tripathy, R. K., Bajaj, P., Suvarnakar, U. V., & Pande, A. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.05.002 · Cited by 18
Associations among smoking status, lifestyle and lipoprotein subclasses
Beauchamp, A., Tonkin, A. M., Peeters, A., Wolfe, R. S., Turrell, G., Harriss, L. R., Giles, G. G., English, D. R., & Jenkins, A. J. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.09.003 · Cited by 16
Bays, H. E., Giezek, H., McKenney, J. M., O’Neill, E. A., & Tershakovec, A. M. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0005 · Cited by 12
Flagged first, then by citations
Cited by
Sorted by citations
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
Self-citationEvacetrapib and cardiovascular outcomes in high-risk vascular disease
Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., Barter, P. J., Brewer, H. B., Fox, K. A. A., Gibson, C. M., Granger, C., Menon, V., Montalescot, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609581 · Cited by 801
Self-citationMendelian randomization in cardiometabolic disease: challenges in evaluating causality
Holmes, M. V., Ala-Korpela, M., & Smith, G. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.78 · Cited by 679
Hypertriglyceridaemia and risk of coronary artery disease
Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 390
Enkavi, G., Javanainen, M., Kulig, W., Róg, T., & Vattulainen, I. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00538 · Cited by 293
Metadata
- Authors
- Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- MedStar Washington Hospital Center (US)
- University of California, Los Angeles (US)
- UNSW Sydney (AU)
- Inserm (FR)
- University of Washington (US)
- Columbia University (US)
- University of Kentucky (US)
- Corresponding author
- Rosenson, Robert S.
- Venue
- Nature Reviews Cardiology
- Published
- 2015-09-01
- Volume
- 13
- Issue
- 1
- Pages
- 48-60
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- PMC
- PMC6245940
- OpenAlex
- W2175680864
- Cited by
- 822
- References
- 131
- Citations by year
- 2026: 89 · 2025: 89 · 2024: 66 · 2023: 79 · 2022: 86 · 2021: 79 · 2020: 79 · 2019: 62 · 2018: 69 · 2017: 61 · 2016: 56 · 2015: 5
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK108209, P30DK017047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- HDL dysfunction, atherosclerosis, apolipoprotein A-I, reverse cholesterol transport, ABCA1, ABCG1, myeloperoxidase, nitrosylation, oxidative modification, inflammation, endothelial function, coronary artery disease, atherogenesis, anti-inflammatory activity
- MeSH terms
- Humans, Lipoproteins, HDL, Macrophages, Smoking, Apolipoprotein A-I, ATP-Binding Cassette Transporters, Diabetes Complications, Atherosclerosis, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
